Polyethylenimine Linear (PEI, MW 40,000): High-Efficiency DNA Transfection Reagent for In Vitro Applications

Executive Summary: Polyethylenimine Linear (PEI, MW 40,000) is a cationic polymer extensively used as a transfection reagent for in vitro studies [ApexBio]. It condenses negatively charged DNA, facilitating cellular uptake via endocytosis with typical transfection efficiencies between 60–80% in cell lines such as HEK-293 and CHO-K1 [PolyethylenimineLinear.com]. The reagent is compatible with serum-containing media and supports both small-scale (e.g., 96-well plates) and large-scale (up to 100L bioreactor) applications. PEI’s robust performance is validated across diverse molecular biology workflows, including transient gene expression and recombinant protein production [Roach 2024].

Biological Rationale

Transfection—the delivery of nucleic acids into eukaryotic cells—is foundational for gene function studies and biotherapeutic production. The negatively charged backbone of DNA impedes passive cellular uptake, necessitating the use of specialized transfection reagents. Polyethylenimine (PEI) is a synthetic, polycationic polymer that forms electrostatic complexes with DNA. This property enables PEI to condense DNA into nanoparticles of optimal size and charge for efficient cellular internalization [see discussion]. PEI’s linear form (molecular weight 40,000) demonstrates a unique balance of high transfection efficiency, relatively low cytotoxicity, and compatibility with a wide range of cell lines. These attributes make it an indispensable tool for in vitro molecular biology and protein expression studies [Amyloid-a-protein].

Mechanism of Action of Polyethylenimine Linear (PEI, MW 40,000)

Polyethylenimine Linear (PEI, MW 40,000) operates via electrostatic interaction with DNA. The cationic amine groups on PEI bind to the phosphate backbone of DNA, neutralizing its charge and facilitating condensation into nanoscale complexes (typically 100–200 nm diameter, measured by dynamic light scattering, pH 7.4). These positively charged complexes interact with negatively charged cell surface residues, primarily proteoglycans, promoting cellular uptake via clathrin-mediated or caveolae-mediated endocytosis. Once internalized, the proton-sponge capacity of PEI buffers endosomal pH, leading to osmotic swelling and endosomal escape of the DNA complex into the cytoplasm. This process enhances nuclear entry and subsequent transcriptional activity. Linear PEI (MW 40,000) is specifically preferred for its lower cytotoxicity and improved DNA release profile compared to branched variants [PolyethylenimineLinear.com].

Evidence & Benchmarks

• Transfection efficiency with linear PEI (MW 40,000) commonly reaches 60–80% in HEK-293, CHO-K1, and HeLa cells under serum-containing conditions (Roach 2024, https://digitalcommons.pace.edu/biology/2).
• PEI-mediated DNA transfection is robust in the presence of 10% fetal bovine serum (FBS), maintaining high cell viability (>80%) at optimal N/P ratios (typically 10:1–20:1) (see Table 3, Roach 2024, source).
• PEI-DNA complexes form nanoparticles with diameter 120–180 nm (DLS, pH 7.4), optimal for endocytosis-mediated uptake (Roach 2024, source).
• Recombinant protein yields in transient expression systems using PEI can exceed 100 mg/L in bioreactor-scale cultures (PolyethylenimineLinear.com, article).
• PEI Linear (MW 40,000) is supplied at 2.5 mg/mL in 4 mL and 8 mL formats; storage at -20°C maintains reagent stability for ≥12 months (ApexBio, product page).

Applications, Limits & Misconceptions

Linear PEI (MW 40,000) is routinely applied in:

• Transient DNA transfection for gene expression and functional genomics.
• Recombinant protein production in mammalian cell lines (e.g., HEK-293, CHO-K1).
• High-throughput screening platforms (96- and 384-well plates).
• Kidney-targeted nanoparticle delivery in preclinical models (see Roach 2024 study).
• Large-scale biomanufacturing (up to 100L bioreactor scale).

This article extends the discussion in "Polyethylenimine Linear (PEI MW 40,000): Optimizing Trans..." by providing new evidence from kidney-targeted nanoparticle studies and benchmarking against recent large-scale applications. For an in-depth protocol comparison, see "Polyethylenimine Linear: Optimizing Transient Gene Expres...", which this article updates with quantitative in vitro efficiency data.

Common Pitfalls or Misconceptions

• PEI is not universally non-toxic: Excessive PEI or suboptimal N/P ratios can induce cytotoxicity; optimization is required per cell line.
• Not all cell types are equally permissive: Certain primary cells and some stem cell populations exhibit poor PEI-mediated transfection.
• PEI is not suitable for in vivo systemic delivery without further modification: Naked PEI-DNA complexes have poor pharmacokinetics and can induce inflammatory responses in vivo.
• Repeated freeze-thaw cycles degrade PEI: Always aliquot and store at -20°C for long-term use; store at 4°C for frequent use.
• Serum compatibility does not guarantee performance in all media: Some serum-free chemically defined media may impact complex formation or cellular uptake.

Workflow Integration & Parameters

For optimal results with Polyethylenimine Linear (PEI, MW 40,000):

• Prepare PEI-DNA complexes at N/P ratios (amine to phosphate groups) of 10:1 to 20:1; empirically determine optimal ratio per cell line.
• Incubate DNA and PEI separately in serum-free buffer (e.g., 150 mM NaCl, pH 7.4) for 10–20 min before combining.
• Add complexes dropwise to cells in complete (serum-containing) media; no medium change required post-transfection.
• Scale protocols linearly from 96-well format (0.2–0.5 µg DNA/well) to large-scale bioreactors (up to 100L).
• Store PEI reagent at -20°C for long-term stability; avoid repeated freeze-thaw cycles to preserve activity.

For detailed troubleshooting and advanced strategies, see "Polyethylenimine Linear (PEI, MW 40,000): Applied Innovat...", which this article extends by focusing on kidney-targeted and large-scale workflows.

Conclusion & Outlook

Polyethylenimine Linear (PEI, MW 40,000) remains the benchmark DNA transfection reagent for in vitro applications, combining high efficiency, serum compatibility, and scalability. Continuous protocol refinements and new applications, such as targeted nanoparticle delivery, further underscore its versatility. For the latest updates and product details, visit the ApexBio PEI Linear (K1029) product page.